Donna Jean Schroeder, PharmD

Sr. Strategist, Founding Partner

What word would you use to describe someone who is deathly afraid of snakes, but thinks frogs are cute, is meticulous when it comes to work but has been known to let a pile of laundry sit for longer than it should, and is not fond of zip-lining but is a million miler flyer on United? Well rounded, perhaps?

Donna is invigorated by movement be it physical activity or product/franchise/pharma advances. She has taken on many hardcore physical challenges such as completing programs like Insanity, P90X, and Betty Rocker, has run a marathon, and is now infatuated with her indoor cycling program where she challenges the leaderboard in live rides and on demand. But back to non-athletic movement.

Donna has been in the industry for over 20 years, and has seen a lot of movement in the pharmaceutical industry. Her first entrée into pharmacy was via her education at the University of California, San Francisco (UCSF), where she graduated, completed two residencies (clinical and administrative), and served on the faculty overseeing the Drug Information Analysis Service. From there, she joined a physician practice management company focusing on treatment guideline development and outcome analyses in oncology. Her work in the medical communications industry began as a Medical Director turned Managing Director in California in four short years. 

Subsequently, Donna founded Helix Communications LLC (an AXIS company at the time). She was selected and hired as President responsible for managing three offices in the United States. Together, Donna and Alden Masonis launched the Helix Europe office. Combined, the Helix offices drove $15M revenue at the peak within six years.

In October 2006, Donna and Founding Partner Alden E. Masonis, PhD, jointly established Percolation Communications LLC. Their focus was, and still is, to convert and improvise on proven theories from other industries when creating solutions for their client partners. In 2011, Alden and Donna launched two new businesses to join Percolation – i.e. Strategy LLC and Powered 4 Significance LLC – under the parent company Blue Ocean Pharma LLC. This family of companies provides client partners with a library of specialized services that address needs across the product lifecycle, including clinical development, commercialization, and medical/marketing communications. The specialized businesses in the Blue Ocean Pharma group share the unified goal of ensuring the success of their client partners while supporting optimal patient care.